Copyright © 1990 by the European Society of Cardiology.
© 1990 The European Society of Cardiology
Early remodelling of the left ventricle in patients with myocardial infarction
Department of Medicine and Nuclear Medicine
* Julius-Maximilian-University Würzburg, F.R.G.
Correspondence: Dr Peter Gaudron, Department of Medicine, University of Würzburg, Josef-Schneider-Strasse 2, 8700 Würzburg, F.R.G.
Sequential alterations of left ventricular volumes and haemodynamics were studied in 29 patiem between 4 days and 4 weeks after myocardial infarction. Left ventricular volume was determined by single photon emission computerized tomography (SPECT), infarct size by creatine k inase (CK) analysis, angiography and thallium201 SPECT. Left ventricular volume index (ml m–2 decreased in patients with small infarcts (74·5 ± 4·9 vs 62·5 ± 3·0, P < 0·005), but increased significantly in patients with moderate (74·6 ± 4·7 vs 83·6 ± 5·0, P < 0·0001) and large (71·7 ± 4·8 vs 90·2 ± 6·5, P < 0·0001) infarctions between 4 days and 4 weeks after acute myocardial infarction. The latter groups contained almost two-thirds of our patients. This dilation occurred without significant changes in filling pressures (Swan-Ganz catheter) and resulted in significant augmentation and finally, normalization of stroke volume at 4 weeks (33·2 ± 3·3 vs 42·6 ± 2·9), despite persistently depressed ejection fraction (conventional radionuclide ventriculography). It is concluded that left ventricular dilatation postmyocardial infarction is structural (unchanged filling pressure) and compensatory (increared stroke volume) during the interval observed in this study.
Key Words: Left ventricular dilatation cardiac performance remodelling myocardial infarction
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Verma, N. S. Anavekar, A. Meris, J. J. Thune, J. M. O. Arnold, J. K. Ghali, E. J. Velazquez, J. J.V. McMurray, M. A. Pfeffer, and S. D. Solomon The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis After Myocardial Infarction: The VALIANT Echo Study J. Am. Coll. Cardiol., September 25, 2007; 50(13): 1238 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Solomon, H. Skali, N. S. Anavekar, M. Bourgoun, S. Barvik, J. K. Ghali, J. W. Warnica, M. Khrakovskaya, J. M. O. Arnold, Y. Schwartz, et al. Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction Circulation, June 28, 2005; 111(25): 3411 - 3419. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J de Kam, A. A Voors, F. Fici, D. J van Veldhuisen, and W. H van Gilst Review: The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era Journal of Renin-Angiotensin-Aldosterone System, December 1, 2004; 5(4): 161 - 168. [Abstract] [PDF] |
||||


